Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: ACT084
MIFTS: 48

Acute Stress Disorder

Categories: Mental diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Acute Stress Disorder

About this section

MalaCards integrated aliases for Acute Stress Disorder:

Name: Acute Stress Disorder 12 15
Stress Disorders, Traumatic, Acute 71
Stress Disorders, Traumatic 71
Traumatic Stress Disorder 12

Classifications:

MalaCards categories:
Anatomical: Mental diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:6088
ICD9CM 34 308.3
UMLS 71 C0029488 C0038441 C0236816
Sources

Summaries for Acute Stress Disorder

About this section
Disease Ontology : 12 An anxiety disorder that has symptom flashbacks, has symptom bad dreams, has symptom frightening thoughts, has symptom avoidance or has symptom hyperarousal of PTSD occurring within one month of a traumatic experience as Acute Stress Disorder or ASD.

MalaCards based summary : Acute Stress Disorder, also known as stress disorders, traumatic, acute, is related to combat disorder and alcohol use disorder, and has symptoms including flashbacks, bad dreams and frightening thoughts. An important gene associated with Acute Stress Disorder is CRP (C-Reactive Protein), and among its related pathways/superpathways are Corticotropin-releasing hormone signaling pathway and Glucocorticoid receptor regulatory network. The drugs Tramadol and Diazepam have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and testes, and related phenotype is homeostasis/metabolism.

Wikipedia : 74 Acute stress disorder (ASD, also known as acute stress reaction, psychological shock, mental shock, or... more...

Sources

Related Diseases for Acute Stress Disorder

About this section

Diseases related to Acute Stress Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 310)
# Related Disease Score Top Affiliating Genes
1 combat disorder 31.9 WARS1 SERPINA3 NENF
2 alcohol use disorder 31.2 SLC6A4 CRH BDNF
3 sleep apnea 31.0 SLC6A4 CRP BDNF
4 somatization disorder 30.9 SLC6A4 CRH
5 neurotic disorder 30.9 SLC6A4 MFSD8 BDNF
6 psychotic disorder 30.6 SLC6A4 SERPINA3 CFI BDNF
7 personality disorder 30.4 SLC6A4 NR3C1 FKBP5 CRHR1 CRH BDNF
8 borderline personality disorder 30.3 SLC6A4 NR3C1 FKBP5 CRHR1 CRH BDNF
9 sleep disorder 30.3 SLC6A4 POMC CRP BDNF
10 substance abuse 30.2 SLC6A4 SERPINA3 OGN CRHR1 CRH BDNF
11 social phobia 30.1 SLC6A4 SERPINA3 CFI
12 bipolar disorder 30.1 SLC6A4 NR3C1 FKBP5 CRP CRHR1 CRH
13 dissociative disorder 30.1 SLC6A4 OGN FKBP5
14 pulmonary disease, chronic obstructive 30.0 SLC6A4 SERPINA3 NR3C1 CRP
15 postpartum depression 30.0 SLC6A4 CRH BDNF
16 tobacco addiction 30.0 SLC6A4 CRHR1 BDNF
17 fibromyalgia 29.8 SLC6A4 POMC CRP CRH BDNF
18 eating disorder 29.8 SLC6A4 POMC CRH BDNF
19 migraine with or without aura 1 29.8 SLC6A4 POMC CRP CRH BDNF
20 depression 29.7 SLC6A4 CRHR1 CRH BDNF
21 retrograde amnesia 29.7 SLC6A4 POMC BDNF
22 substance dependence 29.7 SLC6A4 POMC CRHR1 CRH BDNF
23 generalized anxiety disorder 29.7 SLC6A4 NR3C1 CRP CRHR1 BDNF
24 bulimia nervosa 29.7 SLC6A4 POMC CRH BDNF
25 opiate dependence 29.6 SLC6A4 POMC CRH
26 anorexia nervosa 29.5 SLC6A4 POMC CRH BDNF
27 hypochondriasis 29.5 SLC6A4 POMC BDNF
28 dysthymic disorder 29.5 SLC6A4 NT5M CRH CFI BDNF
29 leptin deficiency or dysfunction 29.5 POMC CRP BDNF
30 irritable bowel syndrome 29.4 SLC6A4 POMC CRHR1 CRH BDNF
31 drug dependence 29.4 SLC6A4 POMC CRHR1 CRH BDNF
32 phobia, specific 29.3 SLC6A4 SERPINA3 NT5M CFI
33 chronic fatigue syndrome 29.3 SLC6A4 POMC NR3C1 CRHR1 CRH
34 adjustment disorder 29.2 SLC6A4 OGN CFI BDNF
35 post-traumatic stress disorder 29.2 SLC6A4 POMC NR3C1 FKBP5 CRP CRHR1
36 disease of mental health 29.2 SLC6A4 SERPINA3 POMC CRP CRHR1 CRH
37 panic disorder 29.1 SLC6A4 POMC CRHR1 CRH BDNF
38 acquired immunodeficiency syndrome 29.1 POMC NR3C1 CRP CRH
39 obsessive-compulsive disorder 28.9 SLC6A4 POMC FKBP5 CRH BDNF
40 alcohol dependence 28.7 SLC6A4 POMC CRHR1 CRH BDNF
41 autism spectrum disorder 28.7 SLC6A4 POMC NR3C1 FKBP5 BDNF
42 mood disorder 28.7 SLC6A4 POMC NR3C1 CRHR1 CRH BDNF
43 schizophrenia 28.6 SLC6A4 SERPINA3 POMC NR3C1 FKBP5 CRP
44 endogenous depression 28.6 SLC6A4 POMC NR3C1 CRP CRHR1 CRH
45 asthma 28.3 SLC6A4 SERPINA3 POMC NR3C1 FKBP5 CRHR1
46 atypical depressive disorder 28.1 SLC6A4 SERPINA3 POMC NR3C1 CRP CRHR1
47 major depressive disorder 28.0 SLC6A4 POMC NR3C1 FKBP5 CRP CRHR1
48 anxiety 27.9 SLC6A4 POMC NR3C1 FKBP5 CRP CRHR1
49 mental depression 27.8 SLC6A4 SERPINA3 POMC NR3C1 FKBP5 CRP
50 chronic pain 10.5

Comorbidity relations with Acute Stress Disorder via Phenotypic Disease Network (PDN):


Anxiety Hypertension, Essential
Intermediate Coronary Syndrome

Graphical network of the top 20 diseases related to Acute Stress Disorder:



Diseases related to Acute Stress Disorder
Sources

Symptoms & Phenotypes for Acute Stress Disorder

About this section

Symptoms:

12
  • • flashbacks
  • • bad dreams
  • • frightening thoughts
  • • avoidance
  • • hyperarousal of ptsd occurring

UMLS symptoms related to Acute Stress Disorder:


agitation, motor restlessness, acute stress/transient/situational disturbance

MGI Mouse Phenotypes related to Acute Stress Disorder:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.44 BDNF CFI CRH CRHR1 CRP FAM163A
Sources

Drugs & Therapeutics for Acute Stress Disorder

About this section

Drugs for Acute Stress Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 327)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
2
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4 439-14-5 3016
3
Ziprasidone Approved Phase 4 146939-27-7 60854
4
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
5
Mifepristone Approved, Investigational Phase 4 84371-65-3 55245
6
Oxytocin Approved, Vet_approved Phase 4 50-56-6 439302 53477758
7
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
8
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
9
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
10
Histamine Approved, Investigational Phase 4 51-45-6 774
11
Haloperidol Approved Phase 4 52-86-8 3559
12
Memantine Approved, Investigational Phase 4 19982-08-2 4054
13
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
14
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
15
Asenapine Approved Phase 4 85650-56-2, 65576-45-6 3001386
16
Levodopa Approved Phase 4 59-92-7 6047
17
Citalopram Approved Phase 4 59729-33-8 2771
18
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
19
Vortioxetine Approved, Investigational Phase 4 508233-74-7 9966051
20
Ondansetron Approved Phase 4 99614-02-5 4595
21
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
22
Diphenhydramine Approved, Investigational Phase 4 147-24-0, 58-73-1 3100
23
Suvorexant Approved, Investigational Phase 4 1030377-33-3
24
Promethazine Approved, Investigational Phase 4 60-87-7 4927
25
Bupropion Approved Phase 4 34911-55-2, 34841-39-9 444
26
Fluvoxamine Approved, Investigational Phase 4 54739-18-3 3404 5324346
27
Carbon monoxide Approved, Investigational Phase 4 630-08-0 281
28
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
29
Pimavanserin Approved, Investigational Phase 4 706779-91-1 16058810
30
Sertraline Approved Phase 4 79617-96-2 68617
31
Propranolol Approved, Investigational Phase 4 525-66-6 4946
32
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
33
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
34
Valproic acid Approved, Investigational Phase 4 99-66-1 3121
35 Olive Phase 4
36 Adrenergic Antagonists Phase 4
37 Antiparkinson Agents Phase 4
38 Autonomic Agents Phase 4
39 Dopamine agonists Phase 4
40 Quetiapine Fumarate Phase 4 111974-72-2
41 Protective Agents Phase 4
42 Hormone Antagonists Phase 4
43 Hormones Phase 4
44 Contraceptives, Postcoital Phase 4
45 Contraceptive Agents Phase 4
46 Contraceptives, Oral Phase 4
47 Luteolytic Agents Phase 4
48 Oxytocics Phase 4
49 Sympathomimetics Phase 4
50 Histamine H1 Antagonists Phase 4

Interventional clinical trials:

(show top 50) (show all 1237)
# Name Status NCT ID Phase Drugs
1 A Prospective Double Blind Randomized Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder Unknown status NCT00134446 Phase 4
2 The Effect of 21-Days Intranasal Oxytocin on Clinical Symptoms and Social Function in Patients With Post Traumatic Stress Disorder (PTSD), a Randomized Controled Trail Unknown status NCT02336568 Phase 4 Oxytoine;PLACEBO
3 A Double-Blind, Placebo-Controlled, Flexible-Dose Pilot Clinical Trial of Once-Daily Extended-Release Tramadol for the Treatment of PTSD Unknown status NCT01517711 Phase 4 Tramadol;Placebo
4 Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure Unknown status NCT00633685 Phase 4 Fluoxetine;Placebo
5 A Randomized Cross Over Trial of Two Treatments for Obstructive Sleep Apnea in Veterans With Post Traumatic Stress Disorder Unknown status NCT01535586 Phase 4
6 Early Pharmacological Intervention With Diazepam in the Emergency Room Setting to Prevent Posttraumatic Stress Disorder (PTSD). Unknown status NCT01221883 Phase 4 Diazepam
7 Double Blind, Placebo-Controlled Trial of THC as add-on Therapy for PTSD Unknown status NCT00965809 Phase 4 Tetrahydrocannabinol
8 Posttraumatic Stress Disorder and Affective Functioning: A Test of the Potentially Normalizing Effects of Oxytocin Unknown status NCT02546570 Phase 4 Oxytocin;Placebo
9 Fear Conditioning, Extinction and Recall in Healthy Subjects and in Obsessive-compulsive Disorder Patients Pre and Post Treatment With Sertraline. Unknown status NCT03068429 Phase 4 Sertraline Hydrochloride
10 Efficacy of an SSRI in Acute Stress Disorder and PTSD Completed NCT00050804 Phase 4 sertraline
11 Neurofunctional Markers of SSRI Treatment Response in PTSD Completed NCT00700999 Phase 4 Paroxetine
12 Reducing Suicidal Ideation Through Treatment of Nightmares-PTSD Completed NCT02199652 Phase 4 Prazosin;Placebo
13 Naltrexone and Cognitive-Behavioral Therapy for Patients With Alcoholism and Post-Traumatic Stress Disorder Completed NCT00006489 Phase 4 Naltrexone;Placebo
14 Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder Among Veterans of Operation Enduring Freedom and Iraqi Freedom (OEF/OIF) Completed NCT01271244 Phase 4 Escitalopram
15 Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes Completed NCT00347269 Phase 4 Psychotropic medication optimization
16 Eszopiclone for the Treatment of PTSD Completed NCT01605253 Phase 4 Eszopiclone;Placebo
17 The Outcome of Treatment of Traumatised Refugees With Trauma-Focused Cognitive Behavioural Therapy and / or Antidepressants - a Randomised Controlled Trial Completed NCT00917397 Phase 4 Sertraline
18 Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder Completed NCT00120250 Phase 4 Eszopiclone
19 Cognitive Behavioral Therapy vs. Sertraline in the Treatment of Post Traumatic Stress Disorder Completed NCT00391430 Phase 4 Sertraline
20 Prophylaxis of Posttraumatic Stress Disorder With Post-Trauma Propranolol Completed NCT00158262 Phase 4 Propranolol;Placebo
21 Randomized Trial of Sertraline, Prolonged Exposure, and Their Combination for Post-traumatic Stress Disorder (PTSD) in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF). Completed NCT01524133 Phase 4 Sertraline
22 Risperidone Monotherapy in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma: a Double-Blind, Placebo Controlled, Randomized Clinical Trial Completed NCT00208182 Phase 4 Risperidone
23 Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) Completed NCT00203463 Phase 4 topiramate
24 The Effect of Intranasal Oxytocin on Emphatic Abilities in Patients With PTSD Completed NCT01325168 Phase 4 syntocinon nasal spray;placebo nasal spray
25 The Effect of Different Dose of Dexmedetomidine Combined With Hydromorphone in Children With Tonsillectomy and Adenoidectomy Completed NCT03760809 Phase 4 Dexmedetomidine 0.5μg／kg;Dexmedetomidine 1μg／kg
26 Combined Treatment With a Benzodiazepine (Clonazepam) and a Selective Serotonin Reuptake Inhibitor (Paroxetine) for Rapid Treatment of Posttraumatic Stress Disorder (PTSD) Completed NCT00025740 Phase 4 clonazepam and paroxetine
27 The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy - a Randomised Clinical Study Completed NCT01569685 Phase 4 Venlafaxine;Sertraline
28 A Pilot Study to Assess the Effects of Doxazosin on Polysomnography in PTSD Completed NCT01959022 Phase 4 Doxazosin XL
29 Geodon (Ziprasidone) for Posttraumatic Stress Disorder Completed NCT00208208 Phase 4 Ziprasidone
30 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians Completed NCT00208130 Phase 4 Topiramate
31 Treatment of Sleep Disturbances in Trauma-affected Refugees: A Randomised Controlled Trial Completed NCT02761161 Phase 4 Mianserin
32 Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy Completed NCT01087736 Phase 4 Topiramate
33 Preventing Post-Operative Delirium in Pneumonectomy, Esophagectomy and Thoracotomy Patients Completed NCT02213900 Phase 4 Haloperidol;Placebo
34 Developing Memory Reconsolidation Blockers as Novel PTSD Treatments Completed NCT01490697 Phase 4 Mifepristone;d-Cycloserine;Placebo-matching Mifepristone;Placebo-matching d-Cycloserine (DCS)
35 Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES Completed NCT00159965 Phase 4 sertraline;placebo
36 Atomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study Completed NCT02287038 Phase 4 Atomoxetine 80 MG
37 An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder Completed NCT02258828 Phase 4 Memantine
38 Combined Mirtazapine and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment of Post-traumatic Stress Disorder (PTSD) Completed NCT01178671 Phase 4 Mirtazapine;Sertraline
39 Interest for a Relative of Seeing Himself Proposing to Witness Resuscitation of a Family Member Victim of a Cardiac Arrest Completed NCT01009606 Phase 4
40 Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD) Completed NCT00560612 Phase 4 Paroxetine;Placebo
41 Combination Treatment for PTSD After the WTC Attack Completed NCT01130103 Phase 4 Paroxetine
42 Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder Completed NCT00674570 Phase 4 Hydrocortisone;D-Cycloserine;Placebo
43 An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder Completed NCT01587118 Phase 4 Adjunctive asenapine
44 A Placebo-controlled Trial of Adjunctive Quetiapine for Refractory PTSD Completed NCT00292370 Phase 4 Open Label (OL) Paroxetine;Placebo;Quetiapine
45 Aripiprazole (Abilify) Therapy for Reducing Comorbid Substance Abuse Completed NCT00208169 Phase 4 Aripiprazole
46 Prazosin Treatment for Combat Trauma PTSD Nightmares and Sleep Disturbance Completed NCT00108420 Phase 4 Prazosin
47 Effects of Paxil CR on Neural Circuits in PTSD Completed NCT00672776 Phase 4 paroxetine;placebo
48 A Double-Blind Placebo-Controlled Trial of Prazosin for the Treatment of Alcohol Dependence Completed NCT00167687 Phase 4 prazosin
49 Telemedicine Outreach for Post Traumatic Stress in CBOCs Completed NCT00821678 Phase 4
50 12 Week Prospective Double Blind Placebo Controlled Randomized Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety Completed NCT00352469 Phase 4 Seroquel XR

Search NIH Clinical Center for Acute Stress Disorder

Sources

Genetic Tests for Acute Stress Disorder

About this section
Sources

Anatomical Context for Acute Stress Disorder

About this section

MalaCards organs/tissues related to Acute Stress Disorder:

40
Brain, Eye, Testes, Amygdala, Heart, Cortex, Prefrontal Cortex
Sources

Publications for Acute Stress Disorder

About this section

Articles related to Acute Stress Disorder:

(show top 50) (show all 10857)
# Title Authors PMID Year
1
Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease. 61
31879693 2020
2
The serotonergic and alpha-1 adrenergic receptor modulator ACH-000029 ameliorates anxiety-like behavior in a post-traumatic stress disorder model. 61
31843397 2020
3
Gender Differences in the Prediction of Acute Stress Disorder From Peritraumatic Dissociation and Distress Among Victims of Violent Crimes. 61
29294663 2020
4
A syndemic of psychosocial health problems is associated with increased HIV sexual risk among Nigerian gay, bisexual, and other men who have sex with men (GBMSM). 61
31608657 2020
5
Addressing the "Myth" of Racial Trauma: Developmental and Ecological Considerations for Youth of Color. 61
31641920 2020
6
Differential effects of prior stress on conditioned inhibition of fear and fear extinction. 61
31891742 2020
7
Genetic association of FKBP5 with PTSD in US service members deployed to Iraq and Afghanistan. 61
31927265 2020
8
Is the mental health profile of immigrants changing? A national-level analysis based on hospital discharges in Italy. 61
31944210 2020
9
Assaying Fear Memory Discrimination and Generalization: Methods and Concepts. 61
31995285 2020
10
Hazardous drinking and clinical correlates among suicidal patients receiving psychiatric inpatient care at military medical settings. 61
31783246 2020
11
Pharmacological rewriting of fear memories: A beacon for post-traumatic stress disorder. 61
31778672 2020
12
Calcineurin Promotes Neuroplastic Changes in the Amygdala Associated with Weakened Cocaine-Cue Memories. 61
31862855 2020
13
Mental health conditions and the risk of chronic opioid therapy among patients with rheumatoid arthritis: a retrospective veterans affairs cohort study. 61
32036583 2020
14
Hair cortisol levels in posttraumatic stress disorder and metabolic syndrome. 61
32008379 2020
15
Psychological interventions for common mental disorders in women experiencing intimate partner violence in low-income and middle-income countries: a systematic review and meta-analysis. 61
31981539 2020
16
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review. 61
31948935 2020
17
Akt dependent adult hippocampal neurogenesis regulates the behavioral improvement of treadmill running to mice model of post-traumatic stress disorder. 61
31759046 2020
18
Clinical Implication of Altered Inhibitory Response in Patients with Post-traumatic Stress Disorder: Electrophysiological Evidence from a Go/Nogo Task. 61
32034577 2020
19
Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis. 61
31874449 2020
20
Mediating role of post-traumatic stress disorder in post-traumatic growth in adults who experienced the 2017 Pohang earthquake. 61
31818784 2020
21
STRAWB2 (Stress and Wellbeing After Childbirth): a randomised controlled trial of targeted self-help materials to prevent post-traumatic stress disorder (PTSD) following childbirth. 61
32034849 2020
22
Family Care Rituals in the ICU to Reduce Symptoms of Post-Traumatic Stress Disorder in Family Members-A Multicenter, Multinational, Before-and-After Intervention Trial. 61
31939785 2020
23
Hippocampal CCR5/RANTES Elevations in a Rodent Model of Post-Traumatic Stress Disorder: Maraviroc (a CCR5 Antagonist) Increases Corticosterone Levels and Enhances Fear Memory Consolidation. 61
32024104 2020
24
Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians. 61
31684805 2020
25
Insomnia symptoms predict the development of post-traumatic stress symptoms following an experimental trauma. 61
31569285 2020
26
Accelerated development of cocaine-associated dopamine transients and cocaine use vulnerability following traumatic stress. 61
31539899 2020
27
Using psychologically informed care to improve mental health and wellbeing for people living with a heart condition from birth: A statement paper. 61
30729809 2020
28
Comorbidity in post-traumatic stress disorder: A population-based study from the two largest cities in Brazil. 61
31780134 2020
29
Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y. 61
31708112 2020
30
Post-traumatic stress disorder, psychiatric comorbidities and associated factors among refugees in Nakivale camp in southwestern Uganda. 61
32033558 2020
31
Attachment styles of People Living with HIV/AIDS. 61
32022190 2020
32
Post-traumatic stress burden in a sample of hospitalized patients with Bipolar Disorder: Which impact on clinical correlates and suicidal risk? 61
31732278 2020
33
Clinical Evaluation of Deployed Military Personnel with Chronic Respiratory Symptoms: STAMPEDE (Study of Active Duty Military for Pulmonary Disease Related to Environmental Deployment Exposures) III. 61
32017933 2020
34
Pharmacologic labour analgesia and its relationship to postpartum psychiatric disorders: a scoping review. 61
32020416 2020
35
PTSD in asylum-seekers: Manifestations and relevance to the asylum process. 61
31822357 2020
36
Neuropsychiatric outcome in subgroups of Intensive Care Unit survivors: Implications for after-care. 61
31739086 2020
37
The Intercontinental Terminals Chemical Fire Study: A Rapid Response to an Industrial Disaster to Address Resident Concerns in Deer Park, Texas. 61
32033278 2020
38
Exploring memory function in earthquake trauma survivors with resting-state fMRI and machine learning. 61
32013935 2020
39
The wounds of childhood: Early trauma subtypes, salience and hyperarousal in a sample of adult psychiatric patients. 61
31933422 2020
40
Post-trafficking stressors: The influence of hopes, fears and expectations on the mental health of young trafficking survivors in the Greater Mekong Sub-region. 61
31272744 2020
41
Panic results in unique molecular and network changes in the amygdala that facilitate fear responses. 61
30108314 2020
42
Angiotensin involvement in trauma processing-exploring candidate neurocognitive mechanisms of preventing post-traumatic stress symptoms. 61
31655485 2020
43
Factors associated with PTSD and partial PTSD among first responders following the Paris terror attacks in November 2015. 61
31821960 2020
44
The use of machine learning techniques in trauma-related disorders: a systematic review. 61
31830722 2020
45
Preparedness and support, not personality, predict satisfaction in unplanned caesarean births. 61
31335233 2020
46
Trauma- and Stress-Induced Craving for Alcohol in Individuals Without PTSD. 61
31812999 2020
47
The effect of Clinical Practice Guidelines on prescribing practice in mental health: A systematic review. 61
31732189 2020
48
Exploring naturally occurring clinical subgroups of post-traumatic headache. 61
32033526 2020
49
Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2. 61
31961649 2020
50
A Comparison of Narrative Exposure Therapy and Non-Trauma-Focused Treatment in Post-Traumatic Stress Disorder: A Systematic Review and Meta-Analysis. 61
31661649 2020
Sources

Variations for Acute Stress Disorder

About this section
Sources

Expression for Acute Stress Disorder

About this section
Search GEO for disease gene expression data for Acute Stress Disorder.
Sources

Pathways for Acute Stress Disorder

About this section

Pathways related to Acute Stress Disorder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Corticotropin-releasing hormone signaling pathway 1
11.3 POMC CRHR1 CRH
2
Glucocorticoid receptor regulatory network 1
11.05 POMC NR3C1 FKBP5
3
Glucocorticoid Pathway (HPA Axis), Pharmacodynamics 60
9.64 POMC CRHR1 CRH
Sources

GO Terms for Acute Stress Disorder

About this section

Cellular components related to Acute Stress Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.23 SERPINA3 POMC OGN NENF CRP CRH

Biological processes related to Acute Stress Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 parturition GO:0007567 8.96 CRHR1 CRH
2 regulation of corticosterone secretion GO:2000852 8.62 POMC CRHR1
Sources

Sources for Acute Stress Disorder

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....